Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The transforming growth factor-beta (TGF-beta) superfamily encompasses a large group of growth and differentiation factors playing important roles in regulating embryonic development and in maintaining tissue homeostasis in adult animals. Using degenerate polymerase chain reaction, we have identified a new murine TGF-beta family member, growth/differentiation factor-8 (GDF-8), which is expressed specifically in developing and adult skeletal muscle. During early stages of embryogenesis, GDF-8 expression is restricted to the myotome compartment of developing somites. At later stages and in adult animals, GDF-8 is expressed in many different muscles throughout the body. To determine the biological function of GDF-8, we disrupted the GDF-8 gene by gene targeting in mice. GDF-8 null animals are significantly larger than wild-type animals and show a large and widespread increase in skeletal muscle mass. Individual muscles of mutant animals weigh 2-3 times more than those of wild-type animals, and the increase in mass appears to result from a combination of muscle cell hyperplasia and hypertrophy. These results suggest that GDF-8 functions specifically as a negative regulator of skeletal muscle growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individuals with sarcopenia have elevated levels of myostatin443, a negative regulator of skeletal muscle growth development444.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [444]
In the citing paper
“In skeletal muscle, the knockout of myostatin (gene symbol Gdf8 , a TGFβ-related ligand) or its 'natural' loss-of-function mutation resulted in a doubling of the muscle size in mice and cattle, respectively (48, 69, 95, 96).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [95]
In the citing paper
“and a myostatin knock out also induces muscle hypertrophy (95).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [95]
In the citing paper
“In animal models, the loss of myostatin signalling, either through the loss of myostatin itself [38, 39] or by targeting the myostatin receptor with antibodies such as bimagrumab causes muscle hypertrophy [23].”
From Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search (2025) · cites this paper as [38]
In the citing paper
“The loss of this gene causes muscle hypertrophy, or double muscling, in many species, including mice [38] and humans [39].”
From Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search (2025) · cites this paper as [38]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Burnette, W. N. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90281-5 · Cited by 8,429
Adipogenesis and Obesity: Rounding Out the Big Picture
Spiegelman, B. M., & Flier, J. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81359-8 · Cited by 1,269
In situ hybridization; a practical approach
(1993) · International Journal of Biochemistry · doi:10.1016/0020-711x(93)90093-t · Cited by 1,220
In situ hybridization; a practical approach
(1993) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(93)90060-h · Cited by 648
Wilkinson, D. G., Bailes, J. A., & McMahon, A. P. (1987) · Cell · doi:10.1016/0092-8674(87)90664-7 · Cited by 576
McPherron, A. C., & Lee, S. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53714-5 · Cited by 318
Self-citationProliferin secreted by cultured cells binds to mannose 6-phosphate receptors.
Lee, S. J., & Nathans, D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69101-x · Cited by 221
Self-citationKnecht, A. K., Good, P. J., Dawid, I. B., & Harland, R. M. (1995) · Development · doi:10.1242/dev.121.6.1927 · Cited by 208
A simple method for carcass analysis
Leshner, A. I., Litwin, V. A., & Squibb, R. L. (1972) · Physiology & Behavior · doi:10.1016/0031-9384(72)90251-x · Cited by 138
Friedman, J. M., & Leibel, R. L. (1992) · Cell · doi:10.1016/0092-8674(92)90402-x · Cited by 137
Cited by
Items 201–300 of 1,061
Dankbar, B., Fennen, M., Brunert, D., Hayer, S., Frank, S., Wehmeyer, C., Beckmann, D., Paruzel, P., Bertrand, J., Redlich, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3917 · Cited by 262
Mechanisms Modulating Skeletal Muscle Phenotype
Blaauw, B., Schiaffino, S., & Reggiani, C. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c130009 · Cited by 256
Day, K., Shefer, G., Shearer, A., & Yablonka-Reuveni, Z. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.01.006 · Cited by 254
Excitation‐transcription coupling in skeletal muscle: the molecular pathways of exercise
Gundersen, K. (2011) · Biological Reviews · doi:10.1111/j.1469-185x.2010.00161.x · Cited by 251
Mammary gland neoplasia: insights from transgenic mouse models
Siegel, P. M., Hardy, W. R., & Muller, W. J. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200006)22:6<554::aid-bies8>3.0.co;2-a · Cited by 58
Dirks, M. L., Wall, B. T., Snijders, T., Ottenbros, C. L. P., Verdijk, L. B., & van Loon, L. J. C. (2014) · Acta Physiologica · doi:10.1111/apha.12200 · Cited by 251
Bilski, J., Pierzchalski, P., Szczepanik, M., Bonior, J., & Zoladz, J. (2022) · Cells · doi:10.3390/cells11010160 · Cited by 251
“MSTN was the first myokine discovered, although it was not initially known by that name [270].”
BackgroundGilson, H., Schakman, O., Kalista, S., Lause, P., Tsuchida, K., & Thissen, J.-P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00193.2009 · Cited by 248
A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
Mendell, J. R., Sahenk, Z., Malik, V., Gomez, A. M., Flanigan, K. M., Lowes, L. P., Alfano, L. N., Berry, K., Meadows, E., Lewis, S., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2014.200 · Cited by 246
Ji, S., Losinski, R. L., Cornelius, S. G., Frank, G. R., Willis, G. M., Gerrard, D. E., Depreux, F. F. S., & Spurlock, M. E. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.4.r1265 · Cited by 246
Relative roles of TGF‐β1 and Wnt in the systemic regulation and aging of satellite cell responses
Carlson, M. E., Conboy, M. J., Hsu, M., Barchas, L., Jeong, J., Agrawal, A., Mikels, A. J., Agrawal, S., Schaffer, D. V., & Conboy, I. M. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00517.x · Cited by 244
Ciarmela, P., Islam, M. S., Reis, F. M., Gray, P. C., Bloise, E., Petraglia, F., Vale, W., & Castellucci, M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr031 · Cited by 244
Skeletal Muscle Wasting and Renewal: A Pivotal Role of Myokine IL-6
Belizário, J. E., Fontes-Oliveira, C. C., Borges, J. P., Kashiabara, J. A., & Vannier, E. (2016) · SpringerPlus · doi:10.1186/s40064-016-2197-2 · Cited by 244
The role of exercise-induced myokines in regulating metabolism
Huh, J. Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0994-y · Cited by 242
Myostatin propeptide‐mediated amelioration of dystrophic pathophysiology
Bogdanovich, S., Perkins, K. J., Krag, T. O. B., Whittemore, L.-A., & Khurana, T. S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2796com · Cited by 242
Nakashima, M., Toyono, T., Akamine, A., & Joyner, A. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00205-6 · Cited by 240
Campbell, C., McMillan, H. J., Mah, J. K., Tarnopolsky, M., Selby, K., McClure, T., Wilson, D. M., Sherman, M. L., Escolar, D., & Attie, K. M. (2017) · Muscle & Nerve · doi:10.1002/mus.25268 · Cited by 240
Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
Heineke, J., Auger-Messier, M., Xu, J., Sargent, M., York, A., Welle, S., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.109.882068 · Cited by 238
Iezzi, S., Di Padova, M., Serra, C., Caretti, G., Simone, C., Maklan, E., Minetti, G., Zhao, P., Hoffman, E. P., Puri, P. L., et al. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00107-8 · Cited by 239
Clinical, Agricultural, and Evolutionary Biology of Myostatin: A Comparative Review
Rodgers, B. D., & Garikipati, D. K. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0003 · Cited by 237
Livshits, G., & Kalinkovich, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100980 · Cited by 237
Bone morphogenetic protein receptor signal transduction in human disease
Gomez‐Puerto, M. C., Iyengar, P. V., García de Vinuesa, A., ten Dijke, P., & Sanchez‐Duffhues, G. (2019) · The Journal of Pathology · doi:10.1002/path.5170 · Cited by 235
A Sequence Polymorphism in MSTN Predicts Sprinting Ability and Racing Stamina in Thoroughbred Horses
Hill, E. W., Gu, J., Eivers, S. S., Fonseca, R. G., McGivney, B. A., Govindarajan, P., Orr, N., Katz, L. M., & MacHugh, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008645 · Cited by 235
Role of TGF-β signaling in inherited and acquired myopathies
Burks, T. N., & Cohn, R. D. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-19 · Cited by 233
Myostatin Inhibits IGF-I-Induced Myotube Hypertrophy through Akt
Morissette, M. R., Cook, S. A., Buranasombati, C., Rosenberg, M. A., & Rosenzweig, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2009 · Cited by 231
Zhu, X., Topouzis, S., Liang, L.-F., & Stotish, R. L. (2004) · Cytokine · doi:10.1016/j.cyto.2004.03.007 · Cited by 230
Allen, D. L., & Unterman, T. G. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00542.2005 · Cited by 229
Benny Klimek, M. E., Aydogdu, T., Link, M. J., Pons, M., Koniaris, L. G., & Zimmers, T. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.123 · Cited by 229
Modulation of myostatin expression during modified muscle use
WEHLING, M., CAI, B., & TIDBALL, J. G. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.103 · Cited by 229
Besse-Patin, A., Montastier, E., Vinel, C., Castan-Laurell, I., Louche, K., Dray, C., Daviaud, D., Mir, L., Marques, M.-A., Thalamas, C., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.158 · Cited by 227
Girgenrath, S., Song, K., & Whittemore, L.-A. (2005) · Muscle & Nerve · doi:10.1002/mus.20175 · Cited by 228
SMASH – semi-automatic muscle analysis using segmentation of histology: a MATLAB application
Smith, L. R., & Barton, E. R. (2014) · Skeletal Muscle · doi:10.1186/2044-5040-4-21 · Cited by 224
Interactions Between Muscle Tissues and Bone Metabolism: INTERACTIONS BETWEEN MUSCLE AND BONE
Kawao, N., & Kaji, H. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25040 · Cited by 228
MiR-206, a Key Modulator of Skeletal Muscle Development and Disease
Ma, G., Wang, Y., Li, Y., Cui, L., Zhao, Y., Zhao, B., & Li, K. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10921 · Cited by 228
Sarcopenia and Muscle Aging: A Brief Overview
Dao, T., Green, A. E., Kim, Y. A., Bae, S.-J., Ha, K.-T., Gariani, K., Lee, M.-R., Menzies, K. J., & Ryu, D. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.405 · Cited by 228
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle
Zhu, X., Hadhazy, M., Wehling, M., Tidball, J. G., & McNally, E. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01570-2 · Cited by 227
Skillington, J., Choy, L., & Derynck, R. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204060 · Cited by 226
Reardon, K. A., Davis, J., Kapsa, R. M. I., Choong, P., & Byrne, E. (2001) · Muscle & Nerve · doi:10.1002/mus.1086 · Cited by 227
Pharmacological strategies for muscular dystrophy
Khurana, T. S., & Davies, K. E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1085 · Cited by 225
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
Winbanks, C. E., Chen, J. L., Qian, H., Liu, Y., Bernardo, B. C., Beyer, C., Watt, K. I., Thomson, R. E., Connor, T., Turner, B. J., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211134 · Cited by 225
Sex-Related Differences in Gene Expression in Human Skeletal Muscle
Welle, S., Tawil, R., & Thornton, C. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001385 · Cited by 224
“Myostatin has a major role in determining muscle size. Constitutive myostatin knockout in mice leads to a hypermuscular phenotype caused by an increased number of fibers and fiber enlargement”
BackgroundHill, J. J., Qiu, Y., Hewick, R. M., & Wolfman, N. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0366 · Cited by 225
Biomarkers in sarcopenia: A multifactorial approach
Curcio, F., Ferro, G., Basile, C., Liguori, I., Parrella, P., Pirozzi, F., Della-Morte, D., Gargiulo, G., Testa, G., Tocchetti, C. G., et al. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.09.007 · Cited by 225
Reed, S. A., Sandesara, P. B., Senf, S. M., & Judge, A. R. (2012) · The FASEB Journal · doi:10.1096/fj.11-189977 · Cited by 223
Acute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults
Welch, C., K. Hassan-Smith, Z., A. Greig, C., M. Lord, J., & A. Jackson, T. (2018) · Aging and disease · doi:10.14336/ad.2017.0315 · Cited by 223
Structural insights into BMP receptors: Specificity, activation and inhibition
Yadin, D., Knaus, P., & Mueller, T. D. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.11.005 · Cited by 221
Caveolinopathies: from the biology of caveolin-3 to human diseases
Gazzerro, E., Sotgia, F., Bruno, C., Lisanti, M. P., & Minetti, C. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.103 · Cited by 220
Winbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., Chen, J. L., Allen, J. M., Lancaster, G. I., Febbraio, M. A., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201109091 · Cited by 218
“, 1990; Lee and McPherron, 2001), which have been demonstrated in many species, including humans (Grobet et al., 1997; Kambadur et al., 1997; McPherron et al., 1997; Zimmers et al., 2002; Schuelke et al., 2004; Clop et al., 2006; Shelton and Engvall, 2007).”
Yang, W., Zhang, Y., Li, Y., Wu, Z., & Zhu, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610185200 · Cited by 218
Regulation of left-right patterning in mice by growth/differentiation factor-1
Rankin, C. T., Bunton, T., Lawler, A. M., & Lee, S.-J. (2000) · Nature Genetics · doi:10.1038/73472 · Cited by 218
Self-citationLin, F., Morrison, J. M., Wu, W., & Worman, H. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi040 · Cited by 218
Fabrication of polymeric biomaterials: a strategy for tissue engineering and medical devices
Khan, F., Tanaka, M., & Ahmad, S. R. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01370d · Cited by 216
Trayhurn, P., Drevon, C. A., & Eckel, J. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2010.535835 · Cited by 214
Candidate growth genes in finfish — Where should we be looking?
De-Santis, C., & Jerry, D. R. (2007) · Aquaculture · doi:10.1016/j.aquaculture.2007.08.036 · Cited by 214
Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice
McCroskery, S., Thomas, M., Platt, L., Hennebry, A., Nishimura, T., McLeay, L., Sharma, M., & Kambadur, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02482 · Cited by 214
Signaling Pathways That Control Muscle Mass
Vainshtein, A., & Sandri, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134759 · Cited by 212
“The TGFβ family can be subdivided into two ligand subfamilies: the TGFβ/activin subfamily and the bone morphogenetic protein (BMP) subfamily, which appear to have opposite roles in skeletal muscle (Figures 1 and 2).”
BackgroundInfluentialRole of Activin A and Myostatin in Human Cancer Cachexia
Loumaye, A., de Barsy, M., Nachit, M., Lause, P., Frateur, L., van Maanen, A., Trefois, P., Gruson, D., & Thissen, J.-P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4318 · Cited by 211
The impact of sleep on age-related sarcopenia: Possible connections and clinical implications
Piovezan, R. D., Abucham, J., dos Santos, R. V. T., Mello, M. T., Tufik, S., & Poyares, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.003 · Cited by 212
Association of handgrip strength with chronic diseases and multimorbidity: A cross-sectional study
Cheung, C.-L., Nguyen, U.-S. D. T., Au, E., Tan, K. C. B., & Kung, A. W. C. (2013) · AGE · doi:10.1007/s11357-012-9385-y · Cited by 212
Dong, J., Dong, Y., Dong, Y., Chen, F., Mitch, W. E., & Zhang, L. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.200 · Cited by 212
Metabolic adaptation in obesity and type ii diabetes: myokines, adipokines and hepatokines
Oh, K.-J., Lee, D., Kim, W., Han, B., Lee, S., & Bae, K.-H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010008 · Cited by 210
Self-citationKim, H., Suzuki, T., Kim, M., Kojima, N., Ota, N., Shimotoyodome, A., Hase, T., Hosoi, E., & Yoshida, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116256 · Cited by 210
Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects
Feldman, B. J., Streeper, R. S., Farese, R. V., & Yamamoto, K. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607501103 · Cited by 210
Walker, R. G., Poggioli, T., Katsimpardi, L., Buchanan, S. M., Oh, J., Wattrus, S., Heidecker, B., Fong, Y. W., Rubin, L. L., Ganz, P., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308391 · Cited by 209
Chauvigné, F., Gabillard, J. C., Weil, C., & Rescan, P. Y. (2003) · General and Comparative Endocrinology · doi:10.1016/s0016-6480(03)00081-9 · Cited by 209
The myokine decorin is regulated by contraction and involved in muscle hypertrophy
Kanzleiter, T., Rath, M., Görgens, S. W., Jensen, J., Tangen, D. S., Kolnes, A. J., Kolnes, K. J., Lee, S., Eckel, J., Schürmann, A., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.123 · Cited by 209
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60740-x · Cited by 208
Expression and function of myostatin in obesity, diabetes, and exercise adaptation
ALLEN, D. L., HITTEL, D. S., & MCPHERRON, A. C. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182178bb4 · Cited by 207
Self-citationDominique, J.-E., & Gérard, C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.04.012 · Cited by 207
Artaza, J. N., Bhasin, S., Magee, T. R., Reisz-Porszasz, S., Shen, R., Groome, N. P., Fareez, M. M., & Gonzalez-Cadavid, N. F. (2005) · Endocrinology · doi:10.1210/en.2005-0362 · Cited by 207
Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease
Schafer, M. J., Atkinson, E. J., Vanderboom, P. M., Kotajarvi, B., White, T. A., Moore, M. M., Bruce, C. J., Greason, K. L., Suri, R. M., Khosla, S., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.023 · Cited by 206
“MSTN is expressed primarily in skeletal muscle and is a robust negative growth regulator (McPherron et al., 1997).”
BackgroundMaternal Obesity, Inflammation, and Fetal Skeletal Muscle Development1
Du, M., Yan, X., Tong, J. F., Zhao, J., & Zhu, M. J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.077099 · Cited by 204
Signaling mechanisms involved in disuse muscle atrophy
Zhang, P., Chen, X., & Fan, M. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.11.043 · Cited by 203
Analysis of myostatin gene structure, expression and function in zebrafish
Xu, C., Wu, G., Zohar, Y., & Du, S.-J. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00635 · Cited by 203
Elevated expression of activins promotes muscle wasting and cachexia
Chen, J. L., Walton, K. L., Winbanks, C. E., Murphy, K. T., Thomson, R. E., Makanji, Y., Qian, H., Lynch, G. S., Harrison, C. A., & Gregorevic, P. (2014) · The FASEB Journal · doi:10.1096/fj.13-245894 · Cited by 202
Myostatin (GDF-8) as a key factor linking muscle mass and bone structure.
Elkasrawy, M., & Hamrick, M. W. (2010) · PubMed · Cited by 243
Zamani, N., & Brown, C. W. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0018 · Cited by 202
The Use of Occlusion Training to Produce Muscle Hypertrophy
Loenneke, J. P., & Pujol, T. J. (2009) · Strength & Conditioning Journal · doi:10.1519/ssc.0b013e3181a5a352 · Cited by 202
BMP signalling in craniofacial development
Nie, X., Luukko, K., & Kettunen, P. (2006) · The International Journal of Developmental Biology · doi:10.1387/ijdb.052101xn · Cited by 203
Transcriptional effects of chronic Akt activation in the heart
Cook, S. A., Matsui, T., Li, L., & Rosenzweig, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201462200 · Cited by 199
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity
Amthor, H., Otto, A., Vulin, A., Rochat, A., Dumonceaux, J., Garcia, L., Mouisel, E., Hourdé, C., Macharia, R., Friedrichs, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811129106 · Cited by 198
Decorin binds myostatin and modulates its activity to muscle cells
Miura, T., Kishioka, Y., Wakamatsu, J.-I., Hattori, A., Hennebry, A., Berry, C. J., Sharma, M., Kambadur, R., & Nishimura, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.060 · Cited by 198
Dubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197
Kovacheva, E. L., Sinha Hikim, A. P., Shen, R., Sinha, I., & Sinha-Hikim, I. (2010) · Endocrinology · doi:10.1210/en.2009-1177 · Cited by 197
Bone and skeletal muscle: neighbors with close ties
DiGirolamo, D. J., Kiel, D. P., & Esser, K. A. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1969 · Cited by 193
Regulation of growth and metabolism by imprinted genes
Smith, F. M., Garfield, A. S., & Ward, A. (2006) · Cytogenetic and Genome Research · doi:10.1159/000090843 · Cited by 196
“Genes with effects on body size and proportions that are exclusively post-natal (e.g. genes encoding growth hormone, growth hormone receptor, Rasgrf1, Gdf8/myostatin, Cdkn1b/ p27 KIP1 ) have also been reported (Nakayama et al., 1996; McPherron et al., 1997; Itier et al., 1998; Lupu et al., 2001).”
BackgroundElevated serum myostatin level is associated with worse survival in patients with liver cirrhosis
Nishikawa, H., Enomoto, H., Ishii, A., Iwata, Y., Miyamoto, Y., Ishii, N., Yuri, Y., Hasegawa, K., Nakano, C., Nishimura, T., et al. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12212 · Cited by 196
Activin signaling as an emerging target for therapeutic interventions
Tsuchida, K., Nakatani, M., Hitachi, K., Uezumi, A., Sunada, Y., Ageta, H., & Inokuchi, K. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-15 · Cited by 195
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21244 · Cited by 194
Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD
Pichavant, C., Aartsma-Rus, A., Clemens, P. R., Davies, K. E., Dickson, G., Takeda, S., Wilton, S. D., Wolff, J. A., Wooddell, C. I., Xiao, X., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.59 · Cited by 193
Brooks, N. E., & Myburgh, K. H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00099 · Cited by 194
Hennebry, A., Berry, C., Siriett, V., O'Callaghan, P., Chau, L., Watson, T., Sharma, M., & Kambadur, R. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00259.2007 · Cited by 193
Tang, H., Inoki, K., Brooks, S. V., Okazawa, H., Lee, M., Wang, J., Kim, M., Kennedy, C. L., Macpherson, P. C. D., Ji, X., et al. (2019) · Aging Cell · doi:10.1111/acel.12943 · Cited by 193
Muscular weakness and muscle wasting in the critically ill
Schefold, J. C., Wollersheim, T., Grunow, J. J., Luedi, M. M., Z'Graggen, W. J., & Weber‐Carstens, S. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12620 · Cited by 193
Zhang, C., McFarlane, C., Lokireddy, S., Masuda, S., Ge, X., Gluckman, P. D., Sharma, M., & Kambadur, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2304-4 · Cited by 192
Myostatin gene silenced by RNAi show a zebrafish giant phenotype
Acosta, J., Carpio, Y., Borroto, I., González, O., & Estrada, M. P. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.04.023 · Cited by 191
Circulating Growth Differentiation Factor 11/8 Levels Decline With Age
Poggioli, T., Vujic, A., Yang, P., Macias-Trevino, C., Uygur, A., Loffredo, F. S., Pancoast, J. R., Cho, M., Goldstein, J., Tandias, R. M., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307521 · Cited by 191
Myostatin and its implications on animal breeding: a review
Bellinge, R. H. S., Liberles, D. A., Iaschi, S. P. A., O'Brien, P. A., & Tay, G. K. (2005) · Animal Genetics · doi:10.1111/j.1365-2052.2004.01229.x · Cited by 192
Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review
White, T. A., & LeBrasseur, N. K. (2014) · Gerontology · doi:10.1159/000356740 · Cited by 191
Tendons of myostatin-deficient mice are small, brittle, and hypocellular
Mendias, C. L., Bakhurin, K. I., & Faulkner, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707069105 · Cited by 192
Metadata
- Authors
- McPherron, A. C., Lawler, A. M., & Lee, S.-J.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Nature
- Published
- 1997-05
- Volume
- 387
- Issue
- 6628
- Pages
- 83-90
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053079324
- Cited by
- 4,013
- References
- 13
- Citations by year
- 2026: 125 · 2025: 124 · 2024: 136 · 2023: 146 · 2022: 200 · 2021: 175 · 2020: 201 · 2019: 174 · 2018: 168 · 2017: 179 · 2016: 190 · 2015: 205 · 2014: 195 · 2013: 186 · 2012: 183
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- myostatin, TGF-beta superfamily, skeletal muscle mass, muscle growth regulation, gene targeting, myotome, muscle hypertrophy, embryonic development
- MeSH terms
- Aging, Amino Acid Sequence, Animals, Body Weight, Cloning, Molecular, Embryo, Mammalian, Cricetinae, Homozygote, Humans, Hyperplasia, Hypertrophy, Mice, Inbred C57BL, Molecular Sequence Data, Stem Cells, Polymerase Chain Reaction, Transforming Growth Factor beta, CHO Cells, In Situ Hybridization, Gene Targeting, Muscle, Skeletal, Protein Sorting Signals, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.